BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sweatt AJ, Miyagawa K, Rhodes CJ, Taylor S, Del Rosario PA, Hsi A, Haddad F, Spiekerkoetter E, Bental-Roof M, Bland RD, Swietlik EM, Gräf S, Wilkins MR, Morrell NW, Nicolls MR, Rabinovitch M, Zamanian RT. Severe Pulmonary Arterial Hypertension is Characterized by Increased Neutrophil Elastase and Relative Elafin Deficiency. Chest 2021:S0012-3692(21)01255-1. [PMID: 34181952 DOI: 10.1016/j.chest.2021.06.028] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Bogaard HJ, Aman J. Neutrophil Elastase: Finding Its Way From Mechanism, via Biomarker to Treatment Target in Pulmonary Hypertension? Chest 2021;160:1177-8. [PMID: 34625167 DOI: 10.1016/j.chest.2021.06.068] [Reference Citation Analysis]
2 Douglas TC, Hannila SS. Working from within: how secretory leukocyte protease inhibitor regulates the expression of pro-inflammatory genes. Biochem Cell Biol 2021;:1-8. [PMID: 34555292 DOI: 10.1139/bcb-2021-0284] [Reference Citation Analysis]
3 Rhodes CJ, Sweatt AJ, Maron BA. Harnessing Big Data to Advance Treatment and Understanding of Pulmonary Hypertension. Circ Res 2022;130:1423-44. [PMID: 35482840 DOI: 10.1161/CIRCRESAHA.121.319969] [Reference Citation Analysis]